F m Investments LLC Purchases 17,660 Shares of UnitedHealth Group Incorporated $UNH

F m Investments LLC grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 150.1% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 29,424 shares of the healthcare conglomerate’s stock after buying an additional 17,660 shares during the quarter. F m Investments LLC’s holdings in UnitedHealth Group were worth $9,713,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the company. LJI Wealth Management LLC grew its stake in UnitedHealth Group by 4.2% during the fourth quarter. LJI Wealth Management LLC now owns 2,883 shares of the healthcare conglomerate’s stock worth $952,000 after buying an additional 117 shares during the last quarter. Ethic Inc. grew its stake in UnitedHealth Group by 2.7% during the fourth quarter. Ethic Inc. now owns 94,010 shares of the healthcare conglomerate’s stock worth $31,034,000 after buying an additional 2,458 shares during the last quarter. Ballast Inc. lifted its position in shares of UnitedHealth Group by 1.6% during the fourth quarter. Ballast Inc. now owns 15,946 shares of the healthcare conglomerate’s stock worth $5,264,000 after purchasing an additional 253 shares in the last quarter. Ballentine Partners LLC lifted its position in shares of UnitedHealth Group by 3.4% during the fourth quarter. Ballentine Partners LLC now owns 16,719 shares of the healthcare conglomerate’s stock worth $5,519,000 after purchasing an additional 550 shares in the last quarter. Finally, Buck Wealth Strategies LLC lifted its position in shares of UnitedHealth Group by 22.2% during the fourth quarter. Buck Wealth Strategies LLC now owns 35,401 shares of the healthcare conglomerate’s stock worth $11,686,000 after purchasing an additional 6,422 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on UNH. UBS Group reduced their target price on shares of UnitedHealth Group from $430.00 to $410.00 and set a “buy” rating on the stock in a research report on Wednesday, January 28th. Oppenheimer upped their target price on shares of UnitedHealth Group from $385.00 to $405.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 22nd. Jefferies Financial Group upped their target price on shares of UnitedHealth Group from $340.00 to $373.00 and gave the stock a “buy” rating in a research report on Monday, April 20th. Weiss Ratings upgraded shares of UnitedHealth Group from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday. Finally, Sanford C. Bernstein increased their price objective on shares of UnitedHealth Group from $405.00 to $411.00 and gave the company an “outperform” rating in a report on Tuesday, April 7th. One analyst has rated the stock with a Strong Buy rating, twenty have assigned a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $378.88.

Insiders Place Their Bets

In related news, CEO Patrick Hugh Conway sold 800 shares of the firm’s stock in a transaction on Thursday, April 23rd. The shares were sold at an average price of $355.00, for a total value of $284,000.00. Following the completion of the transaction, the chief executive officer owned 17,805 shares of the company’s stock, valued at approximately $6,320,775. This trade represents a 4.30% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.28% of the company’s stock.

Key Stories Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth said it will eliminate prior authorization for 30% of healthcare services, a potentially investor-friendly move that may streamline care and reduce complaints about insurer approvals. UnitedHealth to Eliminate Prior Authorization for 30% of Healthcare Services
• Positive Sentiment: Erste Group Bank raised its FY2027 earnings estimate for UnitedHealth, signaling confidence in longer-term profitability, and kept a Buy rating on the stock.
• Neutral Sentiment: UnitedHealth was highlighted in commentary about value stocks and recovery prospects, which may support investor interest but does not appear to be a direct fundamental catalyst. UnitedHealth: Watch The Recovery In Action
• Neutral Sentiment: Zacks Research cut near-term and Q4 2027 earnings estimates, which is a headwind, but the revisions were not as central as the company’s policy change and may reflect more cautious forecasting rather than a major deterioration. Bullish Quarterly Results: 3 Companies Raising Guidance

UnitedHealth Group Stock Up 2.6%

Shares of UNH stock opened at $379.49 on Friday. The firm has a fifty day moving average of $304.54 and a 200-day moving average of $316.98. The company has a quick ratio of 0.79, a current ratio of 0.80 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $387.21. The company has a market capitalization of $344.63 billion, a price-to-earnings ratio of 28.66, a P/E/G ratio of 1.59 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.76 by $0.47. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The company had revenue of $111.65 billion during the quarter, compared to the consensus estimate of $109.84 billion. During the same quarter in the prior year, the firm earned $7.20 earnings per share. The firm’s revenue was up 2.0% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 18.29 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 17th. Stockholders of record on Monday, March 9th were given a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, March 9th. This represents a $8.84 annualized dividend and a dividend yield of 2.3%. UnitedHealth Group’s dividend payout ratio is currently 66.77%.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.